DVA Stock Price Prediction 2026-2027

AI-powered forecast for DaVita HealthCare Partners Inc

Based on Wall Street consensus estimate - Medium Confidence

Data Updated:

Current Price

$110.10

Price Targets for 2027

Bear Case

$121.63

+10.5%

Base Case

$143.00

+29.9%

Bull Case

$164.37

+49.3%

Prediction Tracking

Coming Soon for DVA

Tracking begins January 2026

We are building a comprehensive track record of our AI predictions. Check back to see how our forecasts perform against actual results.

Upcoming Events for DVA

Key Factors Influencing DVA Stock

Bullish Factors

  • Revenue growth of 0.0% year-over-year
  • Significant upside potential to bull case target
  • Market position and competitive advantages

Risk Factors

  • Market volatility and macroeconomic factors
  • Competitive pressures in Medical Care Facilities

Prediction Methodology

These predictions are based on the Wall Street consensus price target of $143.00.

Bull and bear cases are calculated with a reasonable spread around the consensus based on historical volatility.

Get Real-Time Analysis

Access live data, AI insights, and detailed valuations for DVA

Frequently Asked Questions

What is DVA stock price today?

DVA (DaVita HealthCare Partners Inc) stock is trading at $110.10 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is DVA stock going up or down today?

DVA stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy DVA stock now?

The decision to buy DVA depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is DVA a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for DVA based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is DVA stock overvalued or undervalued?

DVA currently trades at a P/E ratio of 11.50, which may suggest attractive valuation. Our DCF calculator provides intrinsic value estimates to help determine if DVA is fairly priced.

What is DVA's P/E ratio?

DVA has a price-to-earnings (P/E) ratio of 11.50, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is DVA's market cap?

DVA (DaVita HealthCare Partners Inc) has a market capitalization of $7.97 billion, making it a small-cap stock.

What is DVA's price to book ratio?

DVA trades at a price-to-book (P/B) ratio of 21.63, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does DVA pay dividends?

DVA does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is DVA's dividend yield?

DVA does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is DVA stock a good long-term investment?

DVA's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is DVA's revenue growth rate?

DVA has shown revenue growth of 0.0% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

Is DVA profitable?

Yes, DVA is profitable with a profit margin of 0.1%. This indicates the company generates 0.1 cents of profit for every dollar of revenue.

What are the risks of investing in DVA?

Key risks for DVA include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does DVA compare to its competitors?

Compare DVA to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize DVA's performance and positioning.

What is DVA's stock price target for 2026?

Our AI model provides price targets for DVA based on fundamental analysis: Bull case $143.13 (+30%), Base case $126.61 (+15%), Bear case $99.09 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about DVA?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for DVA. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is DVA's next earnings report?

DVA reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

Explore Categories

DVA Prediction 2026 | Target: $127 | Lician